Five-year results of ICG-Guided Photodynamic Therapy combined with intravitreal Ranibizumab for juxtapapillary polypoidal choroidal vasculopathy with macular involvement

被引：0
|
作者：
Petropoulos, I. K. [1 ]
Matter, M. A. [1 ]
Desmangles, P. M. [1 ]
机构：
[1] Ophthalmol Ctr Rive, Geneva, Switzerland
来源：
ACTA OPHTHALMOLOGICA | 2014年 / 92卷
关键词：
D O I：
10.1111/j.1755-3768.2014.F070.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
F070
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
    Tadayuki Nishide
    Natsuki Hayakawa
    Misako Nakanishi
    Mai Ishii
    Shinya Okazaki
    Ikuko Kimura
    Etsuko Shibuya
    Nobuhisa Mizuki
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 2415 - 2420
  • [42] Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review
    Zhao, Meng
    Zhou, Hai-Ying
    Xu, Jun
    Zhang, Feng
    Wei, Wen-Bin
    Liu, Ning-Pu
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (03) : 413 - 422
  • [43] Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy:a 2-year result and systematic review
    Meng Zhao
    Hai-Ying Zhou
    Jun Xu
    Feng Zhang
    Wen-Bin Wei
    Ning-Pu Liu
    International Journal of Ophthalmology, 2017, (03) : 413 - 422
  • [44] Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
    Nemoto, Rei
    Miura, Masahiro
    Iwasaki, Takuya
    Goto, Hiroshi
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1633 - 1638
  • [45] Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy
    Masaaki Saito
    Tomohiro Iida
    Mariko Kano
    Kanako Itagaki
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 227 - 235
  • [46] Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy
    Saito, Masaaki
    Iida, Tomohiro
    Kano, Mariko
    Itagaki, Kanako
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (02) : 227 - 235
  • [47] Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
    Fernandez, Maribel
    Gil, Maria
    Gomez-Ulla, Francisco
    Charlon, Pablo
    CASE REPORTS IN MEDICINE, 2012, 2012
  • [48] Half-dose photodynamic therapy alone or combined with ranibizumab in Polypoidal Choroidal Vasculopathy
    Frascio, Pietro
    Nicolo, Massimo
    Rosa, Raffaella
    Musolino, Maria
    Traverso, Carlo Enrico
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [49] Prognostic factors for combined ranibizumab and prompt verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
    Hsia, Yun
    Chan, Li-Wei
    Yang, Chang-Hao
    Yang, Chung-May
    Hsieh, Yi-Ting
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2019, 27 : 227 - 233
  • [50] Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome
    M Ho
    E C F Lo
    A L Young
    D T L Liu
    Eye, 2014, 28 : 1469 - 1476
12345